Health Care & Life Sciences » Biotechnology | Bone Biologics Corp.

Bone Biologics Corp.

Bone Biologics Corp.
Stock Exchange Other OTC
Market Cap
$362.53 M
Shares Outstanding
29 M
Public Float
1.64 M


2 Burlington Woods Drive
Burlington Massachusetts 01803
United States
Employees -
Updated 07/08/2019
Bone Biologics Corp. is an emerging growth company, which engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.


View All

Don Robert Hankey
Stephen R. La Neve
President, Chief Executive Officer & Director